Researchers from NCI and Washington University School of Medicine have developed a blood test that, they believe, could one day offer a highly sensitive and inexpensive approach to detect cancer early in people with NF1.

An NIA-supported study estimated that Covid-19 vaccinations prevented nearly 140,000 deaths in the U.S. by May 2021.

One dose of a new monoclonal antibody discovered and developed at NIH safely prevented malaria for up to 9 months in people exposed to the malaria parasite. The small clinical trial is the first to demonstrate that a monoclonal antibody can prevent malaria in people.

A new study suggests a single 2-hour session of a pain management skills class could offer as much benefit as 8 sessions of cognitive behavioral therapy for patients experiencing chronic low-back pain. Supported by NCCIH and NIDA, the study explored whether a compressed intervention could lead to the same benefits as a longer course of CBT.

A nasal spray of the Oxford/AstraZeneca Covid-19 vaccine protected hamsters and monkeys against serious disease and reduced the amount of virus in the nose. Less virus in the nasal passages could reduce the risk that vaccinated individuals spread the virus.

NEI-funded research offers a new path for preventing glaucoma vision loss. A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma.

People with type 2 diabetes diagnosed during youth have a high risk of developing complications at early ages and have a greater chance of multiple complications within 15 years after diagnosis.

Researchers developed a device to decode brain activity into words in real time, allowing a person with paralysis to communicate in complete sentences.

High-dose buprenorphine therapy, provided under emergency department (ED) care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a NIDA study.

Researchers developed a wirelessly powered temporary pacemaker that breaks down in the body after use. The device can generate enough power to pace a human heart without causing damage or inflammation.